Deutsche Bank

Deutsche Bank’s ARS Pharmaceuticals SPRY Stock Holding History

Deutsche Bank’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$438K	Buy	54,491 +5,764	+12%	+$55.2K	﹤0.01%	2644
2025 Q4	$568K	Buy	48,727 +6,776	+16%	+$65.9K	﹤0.01%	2501
2025 Q3	$422K	Buy	41,951 +4,938	+13%	+$70.9K	﹤0.01%	2645
2025 Q2	$646K	Sell	37,013 -2,090	-5%	-$30.2K	﹤0.01%	2323
2025 Q1	$492K	Sell	39,103 -4,274	-10%	-$51.4K	﹤0.01%	2499
2024 Q4	$458K	Buy	43,377 +14,604	+51%	+$205K	﹤0.01%	2657
2024 Q3	$417K	Buy	28,773 +7,987	+38%	+$95K	﹤0.01%	2567
2024 Q2	$177K	Buy	20,786 +6,042	+41%	+$53.6K	﹤0.01%	2870
2024 Q1	$151K	Sell	14,744 -508	-3%	-$3.79K	﹤0.01%	2978
2023 Q4	$83.6K	Buy	+15,252	New	+$66.8K	﹤0.01%	3300
2022 Q2	–	Sell	-11,140	Closed	-$39K	–	4312
2022 Q1	$39K	Sell	11,140 -1,318	-11%	-$5.74K	﹤0.01%	3912
2021 Q4	$83K	Buy	12,458 +658	+6%	+$5.35K	﹤0.01%	3780
2021 Q3	$118K	Buy	11,800 +4,058	+52%	+$100K	﹤0.01%	3833
2021 Q2	$239K	Sell	7,742 -4,588	-37%	-$147K	﹤0.01%	3683
2021 Q1	$538K	Buy	12,330 +7,330	+147%	+$347K	﹤0.01%	3051
2020 Q4	$232K	Buy	+5,000	New	+$167K	﹤0.01%	3388

Other funds holding SPRY

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return